Biorce has closed a $52.5 million investment round (approximately €44.3 million) with the aim of accelerating the development of its artificial intelligence software for clinical trials and strength...
Read more
Remote monitoring has become increasingly relevant in the digital era, especially following the COVID-19 pandemic, which brought about significant restrictions on travel and in-person contact. This ap...
Read more
In the field of clinical trials, the proper management of participant payments and compensation is a crucial factor in ensuring transparency and ethical research practices. In Europe, regulations set ...
Read more
Biorce, a Barcelona based TechBio company dedicated to transforming clinical trials through artificial intelligence, has announced the successful completion of a €3.5 million funding round. The inve...
Read more
Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.
Read more
From the beginning of the development of any drug until it is available to patients and health professionals, its safety and efficacy must be studied and demonstrated. That is exactly what clinical t...
Read more
Spain is positioned as a leader and benchmark country in advanced therapies, the cornerstone for the treatment of diseases such as cancer, where 62% of clinical trials are conducted.
Read more
Clinical investigations, commonly referred to as clinical trials, play a pivotal role both in developing new treatments and in detecting, diagnosing, and reducing the progression of disease con...
Read more
ORYZON to present further positive efficacy data from iadademstat ALICE Phase IIa trial at the 62nd Congress of the American Society of Hematology
Read more
Early identification of the molecular characteristics of tumors in cancer patients is gaining increasing relevance in the development of anti-cancer therapies. Early molecular profiling influences the...
Read more
The Department of Health, through the General Direction fo Research and Innovation in Health (DGRI) and in collaboration with Biocat, will finance with 4 million euros a total of 19 research and innov...
Read more
Pivotal announced today the acquisition of Akcelis BVBA, a leading full-service provider of patients´ enrollment and retention solutions for clinical trials in the life sciences´ industry.
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
The results show that adenocarcinoma exhibits much more active and fun...
